Latest fiscal year 2024 · computed deterministically from XBRL 10-K data · coverage 83%
In fiscal 2024, AVALON GLOBOCARE CORP. reported revenue of $1M, up 6.2% year over year. Operating margin was -363.1% and net margin -592.7%, on a free-cash-flow margin of n/a with capital expenditure at n/a of revenue. Every figure is computed directly from ALBT's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2024 | $1M | -363.1% | -592.7% |
| FY2023 | $1M | -1254.6% | -1330.5% |
| FY2022 | $1M | -731.4% | -992.4% |
| FY2021 | $1M | -635.1% | -653.5% |
| FY2020 | $1M | -903.9% | -920.3% |
How does ALBT compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.